Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease
Meiyang Xi(Shaoxing University), Haopeng Sun(China Pharmaceutical University), Liping Deng(Shaoxing University), Mengjiao Xie(Shaoxing University), Shejie Chai(Betta Pharmaceuticals (China)), Kui Du(Shaoxing University), Runpu Shen(Shaoxing University), Tian‐Yu Sun(Shenzhen University)
Cited by 31
Related Papers
Palladium-Catalyzed <i>Meta</i>-Selective C–H Bond Activation with a Nitrile-Containing Template: Computational Study on Mechanism and Origins of Selectivity
|Journal of the American Chemical Society|2013|357
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Role of <i>N</i>-Acyl Amino Acid Ligands in Pd(II)-Catalyzed Remote C–H Activation of Tethered Arenes
|Journal of the American Chemical Society|2013|289
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270